Produktinformation
Enprofylline is a phosphodiesterase inhibitor that enhances the levels of cyclic AMP, which has been shown to increase locomotor activity and improve cardiac function. It also has been used to treat bowel disease and fat cell accumulation in the liver. Enprofylline has been shown to be effective in treating diabetic neuropathy, as well as polymerase chain reactions for long-term efficacy. This drug is metabolized by adenosine deaminase, leading to an increased level of adenosine in the body. Human serum contains high levels of adenosine deaminase, which can lead to a decrease in enprofylline's effectiveness if administered intravenously or intramuscularly.
Chemische Eigenschaften
Technische Anfrage zu: Enprofylline
Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern
